ArticleFrontiers in immunology2021

Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1.

Ariana N Renrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.